Hikma’s Vascepa Generic Approved But Launch Still A Mystery
Follows Favorable US District Court Ruling In March
Hikma has eyes on launching a generic of Amarin’s Vascepa in the US following FDA approval and a favorable patent ruling at the district level in March. However, with a swift appeal filed by the originator in the works, the Jordanian firm is yet to pull the trigger.
